54 related articles for article (PubMed ID: 17016622)
1. Multiple splicing variants of Naf1/ABIN-1 transcripts and their alterations in hematopoietic tumors.
Shiote Y; Ouchida M; Jitsumori Y; Ogama Y; Matsuo Y; Ishimaru F; Tanimoto M; Shimizu K
Int J Mol Med; 2006 Nov; 18(5):917-23. PubMed ID: 17016622
[TBL] [Abstract][Full Text] [Related]
2. Expression of two alternatively spliced forms of the 5' untranslated region of the GM-CSF receptor alpha chain mRNA.
Chopra R; Kendall G; Gale RE; Thomas NS; Linch DC
Exp Hematol; 1996 May; 24(6):755-62. PubMed ID: 8635532
[TBL] [Abstract][Full Text] [Related]
3. Folylpoly-gamma-glutamate synthetase gene mRNA splice variants and protein expression in primary human leukemia cells, cell lines, and normal human tissues.
Leclerc GJ; Barredo JC
Clin Cancer Res; 2001 Apr; 7(4):942-51. PubMed ID: 11309345
[TBL] [Abstract][Full Text] [Related]
4. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.
MacGrogan D; Kalakonda N; Alvarez S; Scandura JM; Boccuni P; Johansson B; Nimer SD
Genes Chromosomes Cancer; 2004 Nov; 41(3):203-13. PubMed ID: 15334543
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
Yao KS; Godwin AK; Johnson C; O'Dwyer PJ
Cancer Res; 1996 Apr; 56(8):1731-6. PubMed ID: 8620484
[TBL] [Abstract][Full Text] [Related]
7. MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).
Kozu T; Fukuyama T; Yamami T; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2005 May; 43(1):45-53. PubMed ID: 15723339
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q.
Gao Q; Horwitz M; Roulston D; Hagos F; Zhao N; Freireich EJ; Golomb HM; Olopade OI
Genes Chromosomes Cancer; 2000 Jun; 28(2):164-72. PubMed ID: 10825001
[TBL] [Abstract][Full Text] [Related]
9. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
Larson RA; Le Beau MM
Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
[TBL] [Abstract][Full Text] [Related]
10. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
11. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
[TBL] [Abstract][Full Text] [Related]
12. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines.
Duval A; Rolland S; Tubacher E; Bui H; Thomas G; Hamelin R
Cancer Res; 2000 Jul; 60(14):3872-9. PubMed ID: 10919662
[TBL] [Abstract][Full Text] [Related]
13. Splice variants but not mutations of DNA polymerase beta are common in bladder cancer.
Thompson TE; Rogan PK; Risinger JI; Taylor JA
Cancer Res; 2002 Jun; 62(11):3251-6. PubMed ID: 12036941
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Ikaros family splicing variants in human hematopoietic lineages.
Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M
Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734
[TBL] [Abstract][Full Text] [Related]
15. Transcription factor GATA-2 gene is located near 3q21 breakpoints in myeloid leukemia.
Wieser R; Volz A; Vinatzer U; Gardiner K; Jäger U; Mitterbauer M; Ziegler A; Fonatsch C
Biochem Biophys Res Commun; 2000 Jun; 273(1):239-45. PubMed ID: 10873593
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of a monoclonal antibody specific to Nef-associated factor 1 (Naf1)/A20-binding inhibitor of NF-kappaB activation (ABIN-1).
Chang MO; Yamamoto N; Horiuchi S; Wu YF; Fujimoto M; Yamamoto N
Hybridoma (Larchmt); 2005 Oct; 24(5):248-57. PubMed ID: 16225425
[TBL] [Abstract][Full Text] [Related]
17. A new ERK2 binding protein, Naf1, attenuates the EGF/ERK2 nuclear signaling.
Zhang S; Fukushi M; Hashimoto S; Gao C; Huang L; Fukuyo Y; Nakajima T; Amagasa T; Enomoto S; Koike K; Miura O; Yamamoto N; Tsuchida N
Biochem Biophys Res Commun; 2002 Sep; 297(1):17-23. PubMed ID: 12220502
[TBL] [Abstract][Full Text] [Related]
18. Aberrant TSG101 transcripts in acute myeloid leukaemia.
Lin PM; Liu TC; Chang JG; Chen TP; Lin SF
Br J Haematol; 1998 Aug; 102(3):753-8. PubMed ID: 9722303
[TBL] [Abstract][Full Text] [Related]
19. Single site polymorphisms and alternative splicing of the human CD13 gene--different splicing frequencies among patients with acute myeloid leukaemia and healthy individuals.
Dybkaer K; Kristensen JS; Pedersen FS
Br J Haematol; 2001 Mar; 112(3):691-6. PubMed ID: 11260074
[TBL] [Abstract][Full Text] [Related]
20. High frequency of alternative splicing of human genes participating in the HIV-1 life cycle: a model using TSG101, betaTrCP, PPIA, INI1, NAF1, and PML.
Favre M; Butticaz C; Stevenson B; Jongeneel CV; Telenti A
J Acquir Immune Defic Syndr; 2003 Oct; 34(2):127-33. PubMed ID: 14526201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
